Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Corona Remedies IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
IPO Details
IPO GMP
IPO Subscription
Reviews
About Company
IPO Timeline
KPI
Financial Information
Peer Comparison
Allotment
Corona Remedies Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹24.43 and post-issue EPS of ₹24.43 for FY25. The pre-issue P/E ratio is 43.47x,while the post-issue P/E ratio is 43.47x against the Industry P/E ratio is 43.74x The company's ROE for FY25 is 27.50% and RoNW is 24.65% The Annualised EPS is ₹30.21x and P/E is 35.15x. These metrics suggest that the IPO is Fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 24.43 |
| EPS Post IPO (Rs.) | 24.43 |
| Adjusted 12M EPS Post IPO (Rs.) | 30.21 |
| P/E Pre IPO | 43.47 |
| P/E Post IPO | 43.47 |
| Adjusted 12M P/E Post IPO | 35.15 |
| ROE | 27.50% |
| ROCE | 41.32% |
| P/BV | 10.71 |
| Debt/Equity | 0.1 |
| RoNW | 24.65% |
| EBITDA Margin | 20.55% |
| PAT Margin | 12.43% |
